@article{TAU154389,
author = {Tyrone L. R. Humphries and Xin Dong and Sharon J. Del Vecchio and Aaron J. Urquhart and Robert J. Ellis and Hemamali Samaratunga and Julia Watson and Ross S. Francis and Graham J. Galloway and Glenda C. Gobe and Simon T. Wood and Carolyn E. Mountford},
title = {In vivo proton magnetic resonance spectroscopy of the human kidney and kidney lesions: new protocol},
journal = {Translational Andrology and Urology},
volume = {15},
number = {5},
year = {2026},
keywords = {},
abstract = {Current clinical management of clear cell renal cell carcinoma (ccRCC) frequently requires surgical excision. Surgery for suspected ccRCC is routinely carried out before histopathological diagnosis, yet up to 20% of enhancing small renal masses are benign and could be managed conservatively. Differences in tissue chemistry, using magnetic resonance spectroscopy of human renal neoplasia biopsies, showed a clear distinction between ccRCC, non-ccRCC and healthy kidney tissue. We aimed to develop a preoperative in vivo diagnosis of renal lesions that could better inform the need for surgery or monitoring.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/154389}
}